Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid s PCR Systems Marketed By Barcelona s Izasa

NEW YORK, May 28-The Spanish company Izasa will distribute and market Cepheid SmartCycler quantitative PCR products in much of western Europe, Cepheid said today.


The multi-year agreement covers Spain, Portugal, Italy, Austria, France, the Netherlands and the U.K.


Cepheid will be part of the CH-Werfen "European Partner" sales and marketing holding company, which ties together an international set of instrumentation companies.


Izasa is based in Barcelona.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.